TCBIO

Value 202020212022202320242025 TTM Total common shares outstanding 50.47 M50.63 M48.23 M47.41 M46.01 M44.18 M — Enterprise value —————— — Price to earnings ratio —5.873.095.2615.182.96 26.04 Price to sales ratio —1.470.840.91.060.77 3.92 Price to cash flow ratio —2.16.582.421.92.57 11.26 Price to book ratio —0.470.350.310.30.28 0.51 Enterprise value to EBITDA ratio —————— — Return on assets % 00.010.010.0100.01 0.01 Return on equity % 0.020.080.110.060.020.09 0.09 Return on invested capital % —————— — Gross margin % 67.696.894.3192.8392.2695.42 381.29 Operating margin % 45.7679.9896.6471.7588.1978 301.39 EBITDA margin % 55.1789.94100.5575.7994.4682.35 318.69 Net margin % 8.3227.128.6818.858.9627.5 108.14 Quick ratio —————— — Current ratio —————— — Inventory turnover —————— — Asset turnover 0.020.030.040.040.030.04 0.04 Debt to assets ratio —————— — Debt to equity ratio —————— — Long term debt to total assets ratio 0.010.030.030.030.020.02 0.08 Long term debt to total equity ratio 0.140.290.30.270.20.17 0.71 Operating cash flow per share 52.1912.852.97.6910.247.81 7.78 EBIT per share 7.214.6521.9514.8116.2420.31 19.61 EBITDA per share 8.6916.4822.8315.6517.421.44 20.73 Total debt per share —————— — Cash per share 182.01155.3998.8567.7869.4646.5 256.55 Net current asset value per share 187.56155.5598.8567.7869.4646.5 256.55 Tangible book value per share 53.4556.5653.9559.6165.2672.19 280.51 Working capital per share —————— — Book value per share 53.856.8953.9859.6465.2972.22 280.54